Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na+,K(+)-ATPase in synaptic plasma membranes from cerebral cortex of rats.
Wyse
A T
AT
Depto. Ciências Fisiológicas, FURG, Rio Grande, RS, Brazil.
Wajner
M
M
Brusque
A
A
Wannmacher
C M
CM
D000409:Alanine / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D002540:Cerebral Cortex / Q000201:enzymology*; D007700:Kinetics; D007773:Lactates / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010667:Phenylpyruvic Acids / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013570:Synaptic Membranes / Q000201:enzymology*
D007773:Lactates; D010627:Phenethylamines; D010648:Phenylacetates; D010667:Phenylpyruvic Acids; C017648:3-phenyllactic acid; C029261:phenethylamine; D010649:Phenylalanine; D000254:Sodium-Potassium-Exchanging ATPase; C025136:phenylacetic acid; D000409:Alanine; C031606:phenylpyruvic acid